Pulmonary oxygen uptake and muscle deoxygenation kinetics during heavy intensity cycling exercise in patients with emphysema and idiopathic pulmonary fibrosis by Melitta, McNarry & Michael, Lewis
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in :
BMC Pulmonary Medicine
                                         
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa32958
_____________________________________________________________
 
Paper:
McNarry, M., Harrison, N., Withers, T., Chinnappa, N. & Lewis, M. (2017).  Pulmonary oxygen uptake and muscle
deoxygenation kinetics during heavy intensity cycling exercise in patients with emphysema and idiopathic pulmonary
fibrosis. BMC Pulmonary Medicine, 17(1)
http://dx.doi.org/10.1186/s12890-017-0364-z
 
 
 
 
 
 
 
 
_____________________________________________________________
  
This article is brought to you by Swansea University. Any person downloading material is agreeing to abide by the
terms of the repository licence. Authors are personally responsible for adhering to publisher restrictions or conditions.
When uploading content they are required to comply with their publisher agreement and the SHERPA RoMEO
database to judge whether or not it is copyright safe to add this version of the paper to this repository. 
http://www.swansea.ac.uk/iss/researchsupport/cronfa-support/ 
 RESEARCH ARTICLE Open Access
Pulmonary oxygen uptake and muscle
deoxygenation kinetics during heavy
intensity cycling exercise in patients with
emphysema and idiopathic pulmonary
fibrosis
Melitta A. McNarry1*, Nicholas K. Harrison2,3, Tom Withers1, Narendra Chinnappa3 and Michael J. Lewis1
Abstract
Background: Little is known about the mechanistic basis for the exercise intolerance characteristic of patients with
respiratory disease; a lack of clearly defined, distinct patient groups limits interpretation of many studies. The purpose
of this pilot study was to investigate the pulmonary oxygen uptake ( _V : O2) response, and its potential determinants, in
patients with emphysema and idiopathic pulmonary fibrosis (IPF).
Methods: Following a ramp incremental test for the determination of peak _V : O2 and the gas exchange threshold, six
emphysema (66 ± 7 years; FEV1, 36 ± 16%), five IPF (65 ± 12 years; FEV1, 82 ± 11%) and ten healthy control participants
(63 ± 6 years) completed three repeat, heavy-intensity exercise transitions on a cycle ergometer. Throughout each
transition, pulmonary gas exchange, heart rate and muscle deoxygenation ([HHb], patients only) were assessed
continuously and subsequently modelled using a mono-exponential with ( _V : O2, [HHb]) or without (HR) a time delay.
Results: The _V : O2 phase II time-constant (τ) did not differ between IPF and emphysema, with both groups significantly
slower than healthy controls (Emphysema, 65 ± 11; IPF, 69 ± 7; Control, 31 ± 7 s; P < 0.05). The HR τ was slower in
emphysema relative to IPF, with both groups significantly slower than controls (Emphysema, 87 ± 19; IPF, 119 ± 20;
Control, 58 ± 11 s; P < 0.05). In contrast, neither the [HHb] τ nor [HHb]:O2 ratio differed between patient groups.
Conclusions: The slower _V : O2 kinetics in emphysema and IPF may reflect poorer matching of O2 delivery-to-utilisation.
Our findings extend our understanding of the exercise dysfunction in patients with respiratory disease and may help to
inform the development of appropriately targeted rehabilitation strategies.
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Background
Pulmonary oxygen uptake ( _V : O2) kinetics provides
an insight into the integrated capacity of an organism
to transport and utilize oxygen to support an in-
creased rate of energy turnover in contracting myo-
cytes [1]. This dynamic _V : O2 response is highly
sensitive to both advantageous and deleterious adapta-
tions. For example, the _V : O2 kinetics of patients
with chronic obstructive pulmonary disease (COPD)
are slower than their age-matched controls [e.g. 2–4]
but this can be ameliorated, to some extent, by exer-
cise training [3, 5]. This slow _V : O2 kinetic response
has been suggested to be mechanistically associated
with the reduced exercise tolerance typical of this
population [6–10].
The pathological basis for the slower dynamic _V : O2
response in COPD remains uncertain, with little consen-
sus within the literature regarding the principal determi-
nants of the slower _V : O2 kinetics observed during
moderate intensity exercise. Skeletal muscle dysfunction
characterized by a decreased capillary network [11],
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reduced myoglobin level [12], abnormal oxidative cap-
acity [13, 14] and altered muscle fibre type distribution
(increased relative proportion of type II, glycolytic
muscle fibres [7]) have been suggested to be associated
with the slower _V : O2 kinetics [2, 15] and positive
responses to training reported in some previous studies
[5, 8]. However, others have suggested that the cardio-
vascular derangements often present in those with
COPD may engender an oxygen delivery limitation lead-
ing to the slower dynamic _V : O2 response observed [3,
16], a contention supported by the limited evidence
available regarding the _V : O2 response during heavy in-
tensity exercise [4]. Further interpretation of these find-
ings is limited, however, by methodological limitations
such as the reliance on a single exercise bout for the der-
ivation of _V : O2 kinetics, which may not reflect the true
response [17], and significant potential variability in pa-
tient populations. Specifically, COPD is an umbrella
term that encompasses different pathological entities in-
cluding chronic bronchitis, emphysema, small airways
disease and respiratory bronchiolitis interstitial lung dis-
ease [18]. Some or all of these entities may be present
within an individual in varying proportion.
In contrast to emphysema, there is a paucity of data
on exercise response of patients with fibrotic lung dis-
ease [19]. Idiopathic pulmonary fibrosis (IPF) is a com-
mon life-limiting condition characterized by progressive
deposition of extracellular matrix in the alveolar intersti-
tium. This condition is thought to arise from aberrant
wound healing following alveolar epithelial injury [20]. IPF
results in symptoms of increasing breathlessness, func-
tional decline and eventual death, with a median survival
time of approximately three years following diagnosis [21].
While emphysema and IPF are distinct pathological
conditions, both result in a loss of functional alveolar
units and impaired gas exchange. However, the destruc-
tive process of emphysema causes a loss of elastic recoil
in the lungs, resulting in gas trapping and airflow ob-
struction on expiration with a relative fall in forced ex-
piratory volume (FEV1) compared to forced vital
capacity (FVC). In contrast, increased extracellular
matrix in the alveolar walls of patients with IPF causes
the lungs to fibrose with a consequent reduction in lung
volumes and a matched fall in FEV1 and FVC. Therefore,
the vital capacity of patients with IPF becomes progres-
sively decreased without affecting airflow [20]. The dif-
ferential manifestation of these pathological adaptations
with regards to the _V : O2 kinetics response is presently
unknown, although it is perhaps pertinent to note the
central role of arterial desaturation in exercise intoler-
ance reported in patients with IPF [22, 23].
In this context, the purpose of the present pilot study
was to investigate the _V : O2 kinetics response, during
heavy intensity exercise in well-characterized patients
with emphysema and IPF.
Methods
Participants
Overall, eleven patients and ten healthy volunteers (62.8 ±
6.4 years; 9 males) who served as a control group com-
pleted this study (Table 1). The patient group comprised
of six patients with emphysema (66.4 ± 7.4 years; 5 male;
GOLD classification stage II, n = 1; stage III, n = 3 and
stage IV, n = 2) and five patients with IPF (64.7 ± 11.6 years;
4 males). One patient with emphysema and two with IPF
dropped out due to issues unrelated to the study. Further-
more, one patient with Emphysema was excluded from
the subsequent analyses due to concern regarding the
quality of the data and the values derived.
None of the patients in either group were current
smokers and none had clinical evidence of pulmonary
hypertension. No patient had suffered from a respiratory
infection or an acute exacerbation of their condition over
the six months prior to the study. None of the patients
had been prescribed oral corticosteroids or antibiotics
during this time.
Inclusion criteria for patients with emphysema were: a
history of cigarette smoking, FEV1/FVC ratio <0.7, and
resting arterial PO2 > 60 Torr in room air. In addition, all
emphysema patients had radiographic/CT evidence of
hyperinflation and destruction of lung parenchyma typical
of emphysema. All six patients were taking 18 μg of in-
haled tiotropium daily and five patients were also taking
an inhaled corticosteroid/long acting beta-2 agonist com-
bination, comprising 500 μg of fluticasone and 50 μg of
salmeterol twice daily.
Table 1 Anthropometric characteristics and lung function
according to participant condition
Healthy Emphysema IPF
Age (yrs) 62.8 ± 6.4 66.4 ± 7.4 64.7 ± 11.6
Stature (m) 1.74 ± 0.11 1.67 ± 0.14 1.71 ± 0.07
Body Mass (kg) 76.3 ± 13.9 68.4 ± 8.9 79.0 ± 16.3
BMI (kg · m−2) 25.1 ± 3.3 24.6 ± 2.8 26.7 ± 3.5
BF (%) 26 ± 6 27 ± 9 28 ± 5
FEV1 (%) - 51 ± 25 89 ± 11
a
FVC (%) - 94 ± 27 97 ± 24
FEV1/FVC - 50 ± 14 97 ± 16
a
DLco (%) - 46 ± 17 47 ± 17
Kco (%) - 55 ± 10 65 ± 25
Mean ± SD. BMI: body mass index; BF: body fat; FEV1: Forced Expiratory
Volume in one second; FVC: Forced Vital Capacity; DLco: carbon monoxide
transfer factor; Kco: carbon monoxide transfer coefficient. All parameters of
lung function are expressed as mean percent predicted for age and height
[64, 65]. aSignificant difference between Emphysema and IPF
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All patients with IPF fulfilled the 2011 American Thor-
acic Society/European Respiratory Society criteria for this
diagnosis. In particular, all IPF patients had clinical, radio-
logical and physiological features consistent with a diagno-
sis of IPF. Each patient had undergone high resolution
computed tomography (HRCT) to confirm the presence
of pulmonary fibrosis, with predominant reticular or
honeycomb pattern in the subpleural regions of the lung
bases and little or no ground glass shadowing. One patient
had undergone a surgical lung biopsy, which showed the
histological pattern of usual interstitial pneumonia.
The control group comprised healthy volunteers who
were non-smokers. All were physically active but none
were involved in organized sports.
All participants in the study gave written, informed
consent and the study protocol was approved by the
local NHS Ethics Committee (Ref number: 102547),
which adhered to the Declaration of Helsinki.
Procedures
The participants were asked to arrive at the laboratory in a
rested state, ~2 h postprandial and to avoid strenuous exer-
cise in the 24 h preceding each testing session. The partici-
pants also refrained from taking caffeine for 6 h and
alcohol for 24 h before each test, respectively. All the tests
were performed at the same time of day (±2 h) and exercise
testing was conducted using an electronically braked cycle
ergometer (Lode Excalibur, Groningen, Netherlands).
Incremental Test
The incremental exercise test began with 3 min cycling at
70 – 80 rpm against no additional resistance, followed by
increments of 6–10 W ·min–1 and 20–30 W ·min−1 for
patients and controls, respectively, until exhaustion. These
ramp rates were chosen on the basis of each participant’s
self-reported history of physical activity and symptoms
and are in accord with those utilized in Chiappa et al. [4]
in patients with COPD. The participants were asked to
maintain a cadence of 70–80 rpm. Breath-by-breath pul-
monary gas-exchange data were collected continuously
during the incremental exercise tests (Jaeger, Oxycon Pro,
Carefusion, San Diego). The highest average _V : O2 mea-
sured over 10 s before exhaustion was taken as the peak
_V : O2 ( _V : O2 peak). The gas exchange threshold (GET)
was determined as the _V : O2 at which there was 1) a non-
linear increase in carbon dioxide production (VCO2) rela-
tive to _V : O2 and 2) an increase in minute ventilation
(VE)/ _V : O2 without an increase in VE/VCO2.
Step Exercise Tests
For the determination of _V : O2, heart rate (HR) and deox-
yhemaglobin ([HHb]) kinetics, participants completed a
series of “step” tests. The protocol, which was performed
three times on separate days a minimum of 24 h apart,
comprised 6 min of pedaling with no external resistance
followed by an abrupt transition to the target heavy inten-
sity work rate which was maintained for a further 6 mins.
The heavy intensity work rate was calculated as the work
rate that would elicit a _V : O2 of 40% of the difference
between the GET and peak _V : O2 (Δ40%). Following the
observation of the low mean work rate associated with
Δ40 % in this population (37 ± 12 w), no external resistance
was added to the baseline period to prevent further reduc-
tions in the already small response amplitude. According
to the manufacturer guidelines, “unloaded” pedaling is
equivalent to 10w at 70 rpm. Throughout each exercise
bout, participants maintained a cadence of 70–80 rpm.
Measurements
During the exercise tests, the participants wore a face-
mask and breathed through an impeller turbine assem-
bly (Jaeger Triple V, Hoechberg, Germany). The inspired
and expired gas volumes and gas concentration signals
were continuously sampled at 100 Hz. These analyzers
were calibrated before each test with gases of known
concentrations, and the turbine volume transducer was
calibrated using a 3 l syringe (Hans Rudolph, Kansas
City, MO). The volume and concentration signals were
time-aligned by accounting for the delay in capillary gas
transit and analyzer rise-time relative to the volume sig-
nal. HR was measured throughout the exercise tests
using a three lead echocardiogram (ECG; Reynolds Life-
card CF digital Holter recorder, Spacelabs Healthcare
Ltd., UK). The ECG leads were positioned in the modi-
fied V5, CC5, modified V5R electrode configuration.
This system provided ECG data with a sample accuracy
of 2.5 mV (magnitude of least significant bit; 12-bit reso-
lution) and 1024 Hz sampling frequency.
Additionally, the oxygenation status of the right m.
vastus lateralis was monitored during each transition
using a commercially available near-infrared system
(Portamon, Artinis Medical Systems, The Netherlands).
This system consists of an emission probe which has
three light sources and emits two wavelengths of light
(760 and 850 nm) and a photon detector. The intensity
of incident and transmitted light was recorded continu-
ously at 10 Hz and used to estimate the concentration
changes relative to zero-set baseline levels for oxygen-
ated, deoxygenated, and total hemoglobin. The [HHb]
was used as an indicator of oxygen extraction within the
field of interrogation [e.g. 24, 25]. The contribution of
myoglobin to the NIRS signal is currently unresolved
and so the [HHb] signal described herein should be con-
sidered to refer to the combined concentration of both
deoxygenated hemoglobin and myoglobin. Given recent
evidence regarding the issues of proportionality between
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the _V : O2 and [HHb] response to step exercise, the abso-
lute amplitude changes were not considered [26]. The
muscle was initially cleaned and the portable probe
strapped to the skin at the midpoint of the muscle using
physiotherapists’ tape (Kinesio Tex Gold). To ensure the
device remained stationary during exercise, and to
minimize the interference of extraneous light with the
near-infrared signal, a bandage was wrapped around the
leg to enclose the probe.
_V : O2 kinetics analysis
Initially, the breath-by-breath _V : O2 responses to each step
transition were visually examined to remove any errant
breaths caused by coughing, swallowing, sighing etc., using
a 5-s moving average to identify points lying in excess of
four standard deviations from the local mean. Subse-
quently, each transition was interpolated to 1-s intervals,
time aligned to the start of exercise and averaged to pro-
duce a single response profile. Following baseline correc-
tion, a mono-exponential model with a time delay (Eq. 1)
was then applied to this averaged response:
_VO2 tð Þ ¼ A1⋅ 1−e− t−δ1ð Þ=τ1
 
ð1Þ
where _V : O2 is the increase in _V : O2 at time t above the
baseline value (calculated as the mean _V : O2 from the
first 45 s of the last minute of baseline pedaling), and
A1, δ1 and τ1 are the primary component amplitude,
time delay (which was allowed to vary freely), and time
constant, respectively. Kinetic variables (A1, δ1 and τ1)
and their 95% confidence intervals were determined by
least squares non-linear regression analysis (Graphpad
Prism, Graphpad Software, San Diego, CA). In accord
with previous studies [27–29], a mono-exponential
model was used because a bi-exponential model
Δ _VO2 tð Þ ¼ A1⋅ 1−e− t−δ1ð Þ=τ1
 þ A2⋅ 1−e− t−δ2ð Þ=τ2
  
was
found to produce an inferior and ambiguous fit. Indeed,
given that the purpose of the bi-exponential model is, at
least in part, to identify and characterize the slow compo-
nent, this failure to accurately fit the data is likely attribut-
able to the negligible slow component evident in our
participants, as verified by methods previously described
elsewhere [30]. Briefly, purpose-designed LabVIEW soft-
ware was used which iteratively fitted a single exponential
function to the _V : O2 data until the window encompassed
the entire exercise response. The resulting phase II time
constants were plotted against time to identify the point at
which the phase II time constant consistently deviated from
the previously “flat” profile. The amplitude of the _V : O2
slow component was subsequently determined by calculat-
ing the difference between the end exercise _V : O2 and the
sum of the primary amplitude and baseline _V : O2. This
was expressed both in absolute terms and relative to end-
exercise _V : O2. Finally, the mean response time (MRT),
which reflects the time course of the entire _V : O2 response,
was calculated by fitting a single exponential curve with no
time delay to all data from t = 0.
[HHb] & HR Kinetics Analysis
The [HHb] and HR responses to exercise were also
modelled. The responses to each transition were inter-
polated to 1 s intervals, time-aligned and averaged to
produce a single data set. The time delay for the [HHb]
response ([HHb] TD) was identified as the time after ex-
ercise onset at which [HHb] began a systematic increase
above the nadir value. The [HHb] data were subse-
quently fitted with a single exponential with a time delay
(Eq. 1); the fitting window started at the [HHb] TD and
finished at the end of the exercise transition. In accord
with previous studies [e.g. 29, 31–33], the HR response
was modelled by a mono-exponential without a time
delay (Eq. 2) with the fitting window started at t = 0.
ΔHR tð Þ ¼ A1⋅ 1−e− t=τ1ð Þ
 
ð2Þ
where ΔHR is the increase in heart rate at time t above
the baseline (calculated as the mean heart rate from the
first 45 s of the last minute of baseline pedaling), and A1
and τ1 are the primary component amplitude and time
constant, respectively. The [HHb] time delay and τ were
summed, giving the effective [HHb] τ’ that reflects the
overall time course of the [HHb] response from the on-
set of the step transition. The [HHb]/ _V : O2 ratio was
also calculated to provide a general index of the “excess”
(relative to the steady-state values) O2 extraction for a
given _V : O2 [34]. Specifically, values >1.0 reflect a
greater reliance on fractional O2 extraction compared
with the exercise steady-state (values = 1.0) and reflects a
poorer local O2 delivery relative to muscle O2 utilization
in the area of interrogation. The second-by-second
[HHb] and _V : O2 data were normalised for each partici-
pant and the _V : O2 left-shifted by 20s to account for the
cardiodynamic phase, synchronizing the datasets for ex-
ercise onset. Subsequently, both data sets were averaged
into 5 s time bins and the ratio of [HHb]: _V : O2 was cal-
culated for each time bin from 20 s to the end of exer-
cise. The average of all the individual time bins was
calculated to produce an overall “mean” ratio.
Statistics
Between groups differences (healthy, emphysema or IPF)
were assessed using an ANOVA with subsequent post-hoc
comparisons using Tukey’s test where appropriate to iden-
tify the location of significant differences. Pearson’s prod-
uct moment correlation coefficients were used to analyze
the relationships between key variables. All statistical
analyses were conducted using PASW Statistics 18 (SPSS,
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Chicago, IL). All data are presented as means ± SD. Statis-
tical significance was accepted when P ≤ 0.05.
Results
Peak Exercise
Participant’s peak exercise values are shown in Table 2.
Both patient groups demonstrated a significantly lower
peak _V : O2 than their healthy counterparts in absolute and
relative terms. Emphysema patients had lower absolute
peak _V : O2 than IPF patients, but this difference was elimi-
nated when expressed relative to fat free mass. The absolute
GET was significantly higher in the healthy participants
with no difference evident between emphysema and
IPF patients. When the GET was expressed relative to
peak _V : O2, there were no differences between participant
groups. There were no differences between emphy-
sema and IPF patients in peak tidal volume (VT),
breathing frequency or minute ventilation (VE). IPF dem-
onstrated significantly lower values than healthy partici-
pants for both VT (1.71 ± 0.63 vs. 3.08 ± 0.78 l∙min
−1,
respectively; P = 0.018) and VE (59.2 ± 31.2 vs. 101.4 ±
29.2 l∙min−1, respectively; P = 0.042), whist VE was signifi-
cantly lower in emphysema than healthy participants
(32.0 ± 13.7 vs. 101.4 ± 29.2 l∙min−1, respectively; P = 0.001).
Constant work rate exercise
As summarized in Table 3 and illustrated in Fig. 1, the
dynamic _V : O2 response was significantly influenced by
both lung diseases. Specifically, whilst emphysema and
IPF patients did not differ from each other, both showed
a significantly lower phase II amplitude and relative slow
component amplitude and slower phase II τ and MRT
compared to healthy participants. In contrast, in
addition to being slower than healthy participants, em-
physema patients evidenced a significantly slower HR re-
sponse following the onset of exercise. Emphysema and
IPF patients demonstrated a similar [HHb] τ and effect-
ive [HHb] τ’. The overall [HHb]: _V : O2 ratio did not dif-
fer significantly between IPF and emphysema patients.
Irrespective of patient group, there was a transient
overshoot in the [HHb]: _V : O2 response following the
step change in exercise demand (Fig. 2).
There were no significant differences in steady state
VT (1.85 ± 0.56, 1.59 ± 0.48, 2.21 ± 0.57 l · min
−1), breath-
ing frequency (32.8 ± 6.9, 38.3 ± 6.2, 39.3 ± 4.3 breathes)
or VE (46.7 ± 35.7, 44.0 ± 12.8, 38.1 ± 3.3 l · min
−1) be-
tween emphysema, IPF and healthy participants,
respectively.
A significant relationship was present between peak
_V : O2 and the _V : O2 τ (r = −0.80; P = 0.000), _V : O2
MRT (r = −0.73; P = 0.000), relative slow component per-
centage (r = 0.63; P = 0.008) and HR τ (r = −0.85; P = 0.000).
Furthermore, the _V : O2 τ and HR τ were significantly
related (r = 0.81; P = 0.000). There was no relationship be-
tween the _V : O2 τ and the [HHb]/ _V : O2 ratio.
Discussion
This is the first study to explore the influence of emphy-
sema and IPF on the dynamic adjustments of pulmonary
_V : O2, HR and localized muscle fractional oxygen extrac-
tion during heavy intensity cycling exercise. We found
that both patient groups had impaired exercise responses
with slower _V : O2, and HR kinetics relative to their
healthy counterparts. Interestingly and contrary to our ex-
perimental hypothesis, the _V : O2 and [HHb] response
profiles in emphysema and IPF were similar, although the
former demonstrated a significantly slower HR response.
These findings suggest that, whilst emphysema and IPF
have quite different clinical and histopathological features,
Table 2 Peak exercise response in healthy participants and in
patients with emphysema and IPF
Healthy Emphysema IPF
Peak _V : O2 (l · min
−1) 2.66 ± 0.70 1.35 ± 0.13a 1.41 ± 0.13ab
Peak _V : O2 (l · kg
-0.66 · min−1) 2.06 ± 0.62 1.04 ± .023a 1.06 ± 0.33a
GET (l · min−1) 1.48 ± 0.50 0.80 ± 0.11a 0.95 ± 0.15a
GET (%) 56 ± 12 57 ± 4 67 ± 7
Peak HR (b · min−1) 177 ± 12 142 ± 17* 142 ± 31a
Time to Exhaustion (min) 12.9 ± 3.2 9.5 ± 0.8 11.7 ± 3.5
Mean ± S.D. _V : O2: oxygen uptake; GET: gas exchange threshold.
aSignificant
difference relative to healthy participants (P < 0.05) bSignificant difference
between emphysema and IPF patients
Table 3 Pulmonary _V : O2, HR and [HHb] responses during
heavy intensity exercise according to participant condition
Healthy Emphysema IPF
Baseline _V : O2 0.62 ± 0.9 0.60 ± 0.12 0.75 ± 0.18
_V : O2 Amp (l · min
−1) 1.48 ± 0.54 0.40 ± 0.11a 0.41 ± 0.14a
_V : O2 TD (s) 15 ± 5 11 ± 7 11 ± 7
_V : O2 τ (s) 31 ± 7 65 ± 11a 69 ± 7a
_V : O2 MRT (s) 52 ± 12 81 ± 18
a 92 ± 19a
_V : O2 SC Amp (l · min
−1) 0.19 ± 0.10 0.01 ± 0.01a 0.01 ± 0.01a
_V : O2 SC Amp (% EE _V
: O2) 7 ± 3 1 ± 1
a 1 ± 1a
HR Amp (beats · min−1) 58 ± 11 22 ± 10a 21 ± 10a
HR τ (s) 36 ± 12 119 ± 20a 87 ± 19ab
[HHb] TD (s) NA 18 ± 9 15 ± 2
[HHb] τ (s) NA 51 ± 23 35 ± 29
[HHb] τ’ (s) NA 69 ± 15 54 ± 35
[HHb]: _V : O2 ratio NA 1.07 ± 0.14 1.21 ± 0.07
Work rate (W) 155 ± 56 37 ± 12 64 ± 9
Mean ± S.D. (95% confidence intervals). _V : O2, oxygen uptake; Amp: Amplitude;
TD: time delay; τ: phase II time constant; MRT: mean response time; SC: slow
component; EE: end exercise; HR: heart rate; NA: data not available
aSignificant difference relative to healthy participants (P < 0.05); bSignificant
difference between patients with Emphysema and IPF (P < 0.05)
McNarry et al. BMC Pulmonary Medicine  (2017) 17:26 Page 5 of 10
exercise rehabilitation programs may wish to target the
enhancement of systemic O2 delivery and peripheral
muscle O2 availability to minimize the functional aerobic
fitness impairments typical of people suffering from both
conditions.
The slower pulmonary _V : O2 kinetics in our patients
with emphysema are in accord with those previously re-
ported in COPD patients during both moderate [3, 5]
and heavy intensity exercise [4]. The present study is
novel in that we utilised multiple (rather than single)
heavy intensity exercise transitions and recruited only
those patients with clearly defined emphysema. Conse-
quently, our resulting confidence intervals for τ in the
dynamic responses of _V : O2 (5 ± 2 s), HR (5 ± 3 s) and
[HHb] (2 ± 1 s) are commensurate with those recom-
mended by Fawkner and Armstrong [35], although it is
pertinent to note the potential influence of our chosen
interpolation techniques on these confidence intervals
[36, 37]. Indeed, while three exercise transitions have
been shown be associated with the lowest confidence in-
tervals [at least compared to 1, 2, 4 or 6 transitions; 38],
the applicability of such findings to the small amplitudes
reported in the present study is likely to be limited [39].
The factors that determine the _V : O2 response are still
contentious, yet will be fundamental to the future devel-
opment of effective pulmonary rehabilitation exercise
programs for people with respiratory disease. Previous
studies of moderate and heavy intensity exercise have
suggested that oxygen delivery may represent the pri-
mary rate-limiting factor of the _V : O2 kinetics in COPD
[3, 4, 16]. This assertion is largely based on observations
of impaired HR kinetics, which are thought to provide a
good proxy of the kinetics of cardiac output and muscle
blood flow [40, 41]. However, Chiappa et al. [4] have
suggested that focusing on the dynamic HR may be in-
appropriate as they attributed the slower kinetics of car-
diac output in their patients predominantly to a slower
increase in stroke volume (52% slower τ) rather than
heart rate (40% slower τ). Our observation that patients
with emphysema had a 70% slower HR kinetic response
compared to healthy controls implies a considerable
limitation in central oxygen delivery following the onset
of exercise. This notion is further supported by the
a
b
c
Fig. 1 Pulmonary _V : O2, HR and [HHb] responses during heavy
intensity exercise. A) Pulmonary oxygen uptake response B) heart
rate and C) deoxyheamaglobin responses during heavy intensity
exercise in a representative patient with emphysema (open circles),
IPF (closed circles) and a healthy participant (open triangles). The
solid lines represent the mono-exponential model fit and dashed
lines the onset of the increased work rate
Fig. 2 Representative profiles for the adjustment of [HHb]: _V : O2 during
the step transition to heavy intensity exercise
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[HHb]: _V : O2 ratio which demonstrated an overshoot in
both patient groups at the onset of exercise, with mean
values >1.0 across the exercise transition. This is indicative
of a mismatch between microvascular O2 distribution and
muscle O2 utilisation in the active tissues, requiring a
greater reliance on O2 extraction for a given relative _V : O2
[26, 34]. The values reported in the present study, at least
for the IPF patients, are similar to those recently reported
in untrained older adults [42]. It is interesting to note the
considerably lower values in the emphysema patients, al-
though we accept this may be a methodological artefact
due to the small sample size and low signal-to-noise ratio.
Recent findings in healthy older adults suggest that im-
pairments in the dynamics of O2 delivery may be related
to the slowing of _V : O2 kinetics generally observed with
ageing [43–46]. Given that COPD and IPF typically
present in older adults, it is feasible that the pathological
derangements associated with these diseases may engen-
der further impairments in the dynamics of O2 delivery
and, thus, the _V : O2 kinetic response. Certainly, multiple
perturbations, such as an altered autonomic balance [47]
and altered mechanics and muscle fibre recruitment pat-
terns of breathing [6, 48, 49], have been identified in
people with COPD and could contribute to an O2 delivery
limitation. Furthermore, people with COPD are known to
have an increased cardiac sympathetic tone [30] and at
the onset of exercise, cardiac parasympathetic withdrawal
may be less pronounced compared to their healthy coun-
terparts. Given that sympathetic activation is considerably
slower at increasing heart rate than parasympathetic with-
drawal [50], this autonomic imbalance could explain the
slower HR response at the onset of exercise. Expiratory
flow limitations can result in higher intrathoracic pres-
sures during expiration in those with COPD which could
impair right ventricular filling and left ventricular ejection
[6] and hence further reduce O2 delivery. Indeed, simu-
lated expiratory flow limitations in healthy adults caused
significantly slower recovery _V : O2 kinetics [51]. These
negative cardio-circulatory consequences may addition-
ally, or alternatively, be elicited through the significant
contribution of the abdominal muscles to breathing in
some patients with COPD which similarly increases ex-
piratory pressure [48]. Finally, the increased work of
breathing in those with COPD [6], especially during exer-
cise, may divert a greater proportion of blood flow to the
respiratory muscles, potentially decreasing blood flow and
thus O2 delivery to the exercising muscles [52].
The slower dynamic _V : O2 response in patients with em-
physema may also be caused by factors independent of
cardiac output. For example, increased sympathetic tone
may result in vasoconstriction, impairing muscle blood
flow and thus reducing O2 delivery [53]. Alternatively, it
has been reported that patients with emphysema have ele-
vated plasma levels of tumor necrosis factor-α and
reactive oxygen species [54], which decrease the availabil-
ity of nitric oxide (NO), an important vasodilator in
muscle. However, whilst Berry et al. [55] and Kerley et al.
[56] proposed that dietary nitrate supplementation might
be beneficial, it has recently been demonstrated that this
is ineffective in people with COPD [57].
The notion of an intramyocyte limitation is supported by
the present study in which we observed a slower [HHb] re-
sponse in patients with emphysema compared to published
values for healthy older adults [~8–15 s;43, 45]. It is known
that patients with COPD have a lower muscle oxidative
capacity due to a decreased oxidative enzyme activity, re-
duced mitochondrial density and increased proportion of
type II muscle fibers [58]. The latter have a lower oxidative
but a higher glycolytic capacity and (at least in mouse
muscle) an inherently slower _V : O2 response relative to
type I muscle fibers [59, 60]. Therefore, it could be specu-
lated that a greater reliance on type II muscle fibers in pa-
tients with emphysema during heavy intensity exercise
explains our observed slowing of the dynamic _V : O2 re-
sponse. Further evidence to support this notion was pro-
vided by Casaburi et al. [5] who reported a significantly
faster _V : O2 response in patients with COPD following ex-
ercise training despite no change in HR kinetics. Whilst
the present study was not designed to investigate the
mechanistic basis of the slower _V : O2 kinetics in people
with pulmonary disease, it seems likely to involve impair-
ments in both oxygen delivery and myocyte function.
Dyspnea is the most common and debilitating symptom
in patients with IPF in whom it is the primary impairment
to quality of life [61]. It is therefore surprising that there is
such a paucity of information regarding the physiological
response to heavy exercise in IPF and whether the afore-
mentioned mechanisms relating to emphysema also apply
to this condition. Our findings relating to _V : O2 τ suggest
that patients with emphysema and IPF exhibit similar
overall functional impairment, although modulatory fac-
tors may differ in the two conditions. Specifically, our pa-
tients with emphysema demonstrated an approximately
27% slower HR response than those with IPF and this
might indicate a greater relative impairment of oxygen de-
livery in these patients although our small sample size dic-
tates this difference should be interpreted with caution.
Contrary to expectation and the findings of Chiappa
et al. [4], a negligible O2 slow component was observed
in both patient groups. Whilst this could be due to
methodological limitations related to measurement of
relative exercise intensity in our patients, it is pertinent
to note the exercise until volitional exhaustion in the
study of Chiappa et al. [4]. Given recent advances in our
understanding of the etiology of the slow component
[62, 63], further work is warranted to ascertain the ap-
plicability of such findings to patients with lung disease.
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Whilst we believe the present study extends our under-
standing of the exercise intolerance characteristic of IPF
patients and provides an insight into a clearly defined em-
physema patient group, it has certain limitations. Specific-
ally, [HHb] data was not collected in the healthy control
participants, arterial desaturation was not measured and
the population sizes were relatively small; all these factors
could potentially influence the conclusions we have
drawn. Indeed, it is important that our results are consid-
ered with caution given the lower statistical power associ-
ated with the small sample size. A greater sample size may
also allow questions with regard to the optimal modeling
strategy for [HHb] data to be investigated, with concerns
raised that the present method may not optimally describe
the initial transient response. Moreover, the low response
amplitude and subsequent signal-to-noise ratio requires
caution in the interpretation of the present findings, espe-
cially with regards to potential discrepancies in relative ex-
ercise intensity which may have influenced the presence of
a _V : O2 slow component. It is also pertinent to note the
age of the current participants; underlying age-related de-
clines in the dynamic exercise response limit the attribu-
tion of the observed impairments to solely COPD.
Furthermore, the present study used heart rate kinetics as
a proxy for oxygen delivery and we did not formally assess
dyspnea during exercise. Finally, to limit the burden on
our patients who had relatively severe lung disease, a
supra-maximal validation bout for peak _V : O2 was not
performed. Despite these limitations, we believe this pilot
study provides important information, which could inform
future research into functional limitations of people with
IPF and emphysema.
Conclusions
In conclusion, the pathological conditions of emphysema
and IPF both impair the normal dynamic respiratory and
cardiac responses following the onset of exercise. Specific-
ally, they are characterised by significantly slower _V : O2,
HR and [HHb] kinetics relative to healthy controls, sug-
gesting that both oxygen delivery and metabolic inertia
limit the O2 response in these patients. Our findings may
help in the development of future therapeutic strategies
designed to improve functional aerobic fitness in people
suffering from emphysema and IPF. Specifically, regimes
that target enhanced systemic O2 delivery and peripheral
muscle O2 availability may be particularly effective.
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